Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Aptose Biosciences Inc. (APTO)
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Aptose Biosciences Inc. since year 2005.
Table 2 shows the detailed insider transactions of Aptose Biosciences Inc. since 2005.
The reporting company's ticker symbol is APTO. The reporting company's CIK number is 882361.
The total value of stock buying since 2005 is $77,760.
The total value of stock sales since 2005 is $43,840.
The total value of stock option exercises since 2005 is $0.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2019-06-05||Chow Gregory K. (Senior VP & CFO)||Buy||7,500||1.84||13,815|
|2019-04-18||Rice William G. (Chair, President & CEO)||Buy||10,000||1.85||18,510|
|2019-03-14||Rice William G. (Chair, President & CEO)||Buy||10,000||1.90||18,990|
|2019-03-13||Chow Gregory K. (Senior VP & CFO)||Buy||15,000||1.76||26,445|
Insider trading activities including stock purchases, stock sales, and option exercises of APTO listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Aptose Biosciences Inc. (symbol APTO, CIK number 882361) see the Securities and Exchange Commission (SEC) website.